Camille Terfve - October 29, 2024 Alchemab: the art of AI antibody discovery Alchemab’s artificial intelligence platform enables the identification of antibodies for some of ...
Joanna Smith - June 10, 2024 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Camille Terfve - May 31, 2024 How data changed our understanding and care of breast cancer Breast cancer does not only affect women, but it mostly affects them1. Breast cancer is the most ...
Camille Terfve - April 26, 2024 The brilliant dawn of AI drug discovery Computer simulations are solving challenges previously thought uncrackable.
Eliot Ward - February 29, 2024 The link between the microbiome and chronic liver disorders Guts UK is the charity for the digestive system. It funds scientific research such as Nicholas ...
Joanna Smith - July 4, 2023 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Camille Terfve - January 31, 2023 Meet the team: Camille Terfve, Partner and Patent Attorney in the Life Sciences team, Cambridge As part of our 'meet the team' series, we talk to Camille Terfve about her journey to becoming a ...
Camille Terfve - October 17, 2022 Bioinformatics at the UK IPO – what does the new Guidance mean for applicants? As recently publicised, the UK IPO recently issued new guidance relating to examining patent ...
Camille Terfve - November 16, 2021 From academia to patents – a career path to becoming a patent attorney Camille Terfve spoke to EMBL Careers about what it takes to become a patent attorney. This was ...
Christopher Casley - October 21, 2021 A snapshot: Patent Landscape in Bioinformatics and Digital Health In this Forward: On Demand vlog, Christopher Casley gives us an overview of our special report on ...
Camille Terfve - August 5, 2021 Patent Landscape in Bioinformatics and Digital Health Special Report Our new Special Report, Patent Landscape in Bioinformatics and Digital Health: a data driven ...
Camille Terfve - May 20, 2021 Intellectual property and artificial intelligence in the UK: what might the future hold? AI is a hot topic for the current UK government. Last year, the UK Intellectual Property Office ...
Helen Bower - May 10, 2021 EPO Opposition Trends in Engineering, Electronics and Software Special Report In autumn 2020, we analysed more than 8000 opposition cases filed at the European Patent Office ...
Camille Terfve - December 3, 2020 Deep learning cracks the protein folding problem? Deep learning has just made a new headline grabbing achievement: DeepMind’s latest AI-powered ...
Camille Terfve - September 24, 2020 Genomics medicine has already proved its potential: the (success) story of non-invasive prenatal testing We have previously discussed the tremendous progress made towards the adoption of genomics medicine ...
Seán Walton - July 24, 2020 Oppositions & Appeals: novelty of a patient sub-population Case 9 – T 734/12 (EPO Board of Appeal, 17 May 2013)
Camille Terfve - July 14, 2020 Can software be therapeutic? The simple answer is: yes. Thanks for reading this post, stay tuned for more answers to your ...
Camille Terfve - July 6, 2020 Protecting IP in bioinformatics and digital health: tips and tricks to tackle the “moving target problem” As previously discussed, data driven approaches have revolutionised research and R&D in the ...
Simon Kiddle - June 29, 2020 Oppositions & Appeals: we helped determine the meaning of “surgery” Case 8 – T 1695/07 (EPO Board of Appeal, 28 September 2011)
Camille Terfve - June 23, 2020 A Guide to Patenting Bioinformatics Inventions at the EPO: what is technical and why does it matter? Many inventions in the field of bioinformatics (a term that we will use herein to encompass ...
Camille Terfve - June 3, 2020 Have we entered the era of the DIY superhuman? Self-improvement products are everywhere around us, on our bookshelves and supermarket shelves ...
Camille Terfve - April 23, 2020 Coronavirus (COVID-19), big data and silver linings There is no denying that the COVID-19 pandemic will have tremendous practical and economic impact ...
Camille Terfve - April 6, 2020 What use is computational biology during the coronavirus (COVID-19) pandemic? There is one obvious way in which computational biology is showing its strengths in the current ...
Camille Terfve - March 9, 2020 Bioinformatics, data and healthcare: Benefits and challenges of data-driven medicine Algorithms (sometimes collectively referred to as ‘digital health’) are changing the way that ...
Camille Terfve - February 14, 2020 Genomics and Biodata in 2020: the future is here! I have been working in the field of bioinformatics/computational biology for 10 years now and have ...
Camille Terfve - February 7, 2020 Genomics and Biodata in 2020: so much data, so little time? Having attended the Festival of Genomics & Biodata 2020 conference last week, it is clear that ...
Camille Terfve - January 23, 2020 Simulations in bioinformatics and the G1/19 referral What’s all this about? Claims directed to methods of simulation or modelling of a system or process ...
Camille Terfve - January 2, 2020 AI, deep learning and image analysis in bioinformatics Putting “AI” in the title of your paper, or indeed in the name of your company, seems to have ...
Camille Terfve - October 30, 2019 EPO Bioinformatics Roadshow There is still a relatively prevalent view in the field of bioinformatics and medical informatics ...
Camille Terfve - September 4, 2019 DIY biology dilemma – regulating biohacking Science kits may have inspired generations of children to become scientists, and those grown up ...
Camille Terfve - August 15, 2019 Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance In this article, Paul Liu and Ashley Barton from Duane Morris LLP provided some interesting ...
